T1	Protein 13 16	Sp1
T2	Protein 566 569	Sp1
T3	Protein 768 771	Sp1
T4	Protein 851 854	PHA
T5	Protein 859 872	interleukin 2
T6	Protein 942 945	Tat
T7	Protein 1030 1033	SP1
T8	Protein 1124 1128	PP2A
T9	Protein 1228 1231	Tat
T10	Protein 1237 1240	Sp1
T13	Exp 264 266	we
T14	Exp 276 280	that
T15	Exp 336 340	both
T16	Exp 150 186	the purely enhancer-dependent effect
T17	Exp 215 227	the activity
T18	Exp 231 256	the HIV regulatory region
T19	Exp 341 353	the enhancer
T20	Exp 369 390	the factor NF-kappa B
T21	Exp 396 415	the promoter domain
T22	Exp 419 426	the LTR
T23	Exp 428 444	The inducibility
T24	Exp 591 602	the ability
T25	Exp 606 618	the TATA box
T26	Exp 627 642	the protein TBP
T27	Exp 647 651	both
T28	Exp 739 779	the constitutively expressed Sp1 protein
T29	Exp 783 794	the nucleus
T30	Exp 647 686	both transformed and normal lymphocytes
T31	Exp 1005 1016	Our results
T32	Exp 1025 1029	that
T33	Exp 1091 1128	the serine-threonine phosphatase PP2A
T34	Exp 1142 1155	the formation
T35	Exp 1251 1264	The formation
T36	Exp 1345 1367	the low basal activity
T37	Exp 1371 1382	the HIV LTR
T38	Exp 1268 1280	this complex
